NeuroPsy InfoHub — informație de încredere despre neurodiversitate

StudiuDepresieÎncredere bună26.06.2026

Distinct Trajectories of Amygdala Connectivity Patterns Characterize Remission vs. Non-Remission in Major Depressive Disorder

A longitudinal fMRI study tracked 48 patients with major depressive disorder over 8 weeks to identify neural biomarkers of treatment response, finding differential amygdala-supplementary motor area connectivity patterns between those who remitted versus those who did not respond to antidepressants. While baseline connectivity correlated with treatment outcomes and normalized with successful treatment, the findings require replication as they did not survive multiple comparisons correction.

StudiuDepresieÎncredere bună26.06.2026

Association between childhood trauma and 26-week treatment response in adolescents with major depressive disorder: a cohort study

This prospective cohort study of 150 adolescents with major depressive disorder found high prevalence of childhood trauma (emotional abuse 52%, emotional neglect 61.3%), with emotional abuse and neglect significantly associated with poorer treatment response at 26-week follow-up. The findings suggest childhood trauma adversely impacts antidepressant treatment efficacy in adolescents and highlight the need for trauma-informed care in depression management.

StudiuDepresieÎncredere înaltă26.06.2026

Psychiatric Comorbidities Associated with Hormonal Contraceptive Use: A Scoping Review and Meta-Analysis (2014–2024)

This systematic scoping review synthesized evidence from 46 studies (2014–2024) on associations between hormonal contraceptive use and psychiatric outcomes. Meta-analysis found small but statistically significant increases in depressive symptoms with progestin-only methods (RR=1.24) and inconsistent evidence for anxiety and suicidality, with high heterogeneity across studies highlighting the need for individual risk assessment.

PresăDepresieÎncredere bună25.06.2026

Personalized Brain Imaging to Guide Transcranial Magnetic Stimulation for Treatment-Resistant Depression

A randomized clinical trial from Mass General Brigham demonstrates that using personalized brain imaging to tailor transcranial magnetic stimulation (TMS) treatment may enhance outcomes for patients with treatment-resistant depression. The findings, published in JAMA Psychiatry, suggest individualized neuroimaging-guided approaches could improve the efficacy of this FDA-approved therapeutic intervention.

StudiuDepresieÎncredere bună22.06.2026

Editorial: Neurocognitive Disorders and Depression—Complex Interrelationships

This editorial examines the intricate connections between neurocognitive disorders and depression, highlighting how these conditions frequently co-occur and influence one another. The piece addresses the clinical and research implications of understanding these interrelationships for improved patient assessment and treatment approaches.

StudiuDepresieÎncredere înaltă22.06.2026

CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk

This study identifies a genetic variant (CALHM2 V136G) that impairs ATP release from brain cells and is associated with both depression and Alzheimer's disease risk. Using engineered mouse models, researchers demonstrated that this mutation causes depressive-like behaviors and cognitive decline, which could be reversed by ATP supplementation, suggesting a novel biological mechanism linking depression to neurodegeneration.

StudiuDepresieÎncredere înaltă22.06.2026

Impact of Depression and Antidepressant Treatment on Outcomes After Thumb Carpometacarpal Surgery

This clinical study investigates how major depressive disorder and antidepressant use affect patient-reported functional outcomes in the year following thumb carpometacarpal arthroplasty for arthritis. The researchers hypothesized that depressed patients would experience poorer upper-extremity recovery compared to non-depressed surgical patients.

StudiuDepresieÎncredere bună21.06.2026

Vulvar Lichen Sclerosus Associated with Increased Risk of Depression and Anxiety Diagnoses

A large database study found that vulvar lichen sclerosus (a chronic skin condition causing intense itching) is associated with significantly higher rates of depression, anxiety disorder, and major depressive disorder diagnoses compared to non-vulvar lichen sclerosus. Early treatment of vulvar lichen sclerosus was associated with reduced risk of these psychiatric conditions.

StudiuDepresieÎncredere bună21.06.2026

Gym Usage and Exercise Physiology Services in an Australian Private Psychiatric Hospital: A File Audit

This audit examined the extent of gymnasium and exercise physiologist utilization among 100 patients discharged from a private psychiatric inpatient unit, finding that only 24% had documented gym attendance, with higher usage among those with substance use disorders than affective disorders. The study recommends standardized procedures for exercise assessment and referral, as those potentially most benefiting from exercise coaching were underrepresented in exercise physiology referrals.

StudiuDepresieÎncredere înaltă21.06.2026

Bipolar II Disorder: Understudied and Underdiagnosed

Bipolar II disorder remains underrecognized despite its official diagnostic status since 1994, leading to diagnostic delays averaging over 10 years and inappropriate antidepressant treatment. This review examines differential diagnosis, disease course, comorbidities, and suicide risk while identifying critical gaps in bipolar II-specific treatment research and differences from bipolar I in treatment response.

StudiuDepresieÎncredere bună20.06.2026

Home-Based Transcranial Direct Current Stimulation for Cognitive Function in Bipolar Depression

A 6-week home-based tDCS intervention targeting 44 adults with moderate-to-severe bipolar depression showed significant improvements in short-term verbal memory and trends toward better learning and processing speed. The portable, supervised protocol demonstrates feasibility and potential therapeutic benefit for cognitive deficits associated with bipolar depression, though larger studies are needed.

StudiuDepresieÎncredere bună19.06.2026

Self-Injury Mortality: Global Ascertainment and Prevention

This review examines self-injury mortality as a public health measure, arguing that actual suicide and self-harm deaths are significantly underreported globally—potentially exceeding 1.4 million annually when accounting for misclassified substance use deaths. The authors advocate for evidence-based interventions targeting underlying mental disorders (depression, bipolar disorder, schizophrenia, eating disorders, gambling disorder, and substance use) through informed clinical care and community support.

StudiuDepresieÎncredere bună19.06.2026

Real-world Effectiveness of SAINT® (Accelerated Theta-Burst Stimulation) for Treatment-Resistant Depression in Diverse Clinical Settings

This open-label multicenter study evaluated SAINT®, a functional connectivity-guided form of intermittent theta-burst stimulation, in 101 adults with major depressive disorder who had not responded adequately to antidepressants. Treatment involved a 5-day protocol with 68.3% achieving significant improvement and 89.1% showing meaningful clinical benefit, with consistent results across sites and baseline severity levels.